SEC Form 4 · accession 0000899243-18-007583
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas J Virca
Officer — President and CEO
Period of report
Mar 13, 2018
Accepted (ET)
Mar 15, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option | $0.2722 | Mar 13, 2018 | A | 310,000 | A | Mar 13, 2018 | Mar 13, 2028 | Common Stock | 310,000 | 310,000 | D |